KHEDEZLA Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
KHEDEZLA General Information
Description
A portfolio of anti-depressive pharmaceutical brand. The drug is used for the treatment of major depressive disorder.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
- United States
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Corporate Office
- United States
KHEDEZLA Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
KHEDEZLA Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
KHEDEZLA FAQs
-
Where is KHEDEZLA headquartered?
KHEDEZLA is headquartered in .
-
What industry is KHEDEZLA in?
KHEDEZLA’s primary industry is Buildings and Property.
-
Is KHEDEZLA a private or public company?
KHEDEZLA is a Private company.
-
What is KHEDEZLA’s current revenue?
The current revenue for KHEDEZLA is .
-
Who are KHEDEZLA’s investors?
RVL Pharmaceuticals has invested in KHEDEZLA.
-
When was KHEDEZLA acquired?
KHEDEZLA was acquired on 27-Feb-2014.
-
Who acquired KHEDEZLA?
KHEDEZLA was acquired by Currax Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
